Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Invitro International (IVRO)

Invitro International (IVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
InVitro International Reports Positive First Half and Second Quarter FY '24 Results; Also Planning an OTC Markets Uplisting Newsfile - Thu May 2, 8:12AM CDT

Placentia, California--(Newsfile Corp. - May 2, 2024) - Today, InVitro International (OTC Pink: IVRO), announced second quarter FY '24 sales of $210,615, up 5.8% compared to $199,090 for the same period...

IVRO : 0.0600 (+19.05%)
InVitro International Sees Real Positives in Start to FY '24 Newsfile - Wed Feb 14, 8:06AM CST

Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies,...

IVRO : 0.0600 (+19.05%)
InVitro International Announces Fiscal Year End 2023 and Continues Positives Newsfile - Mon Nov 13, 2023

Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies,...

IVRO : 0.0600 (+19.05%)
IVRO Announces Fiscal Q #3 2023 Results While Continuing M&A Strategy to Make Non-Animal Testing Famous Newsfile - Wed Aug 9, 2023

Placentia, California--(Newsfile Corp. - August 9, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023...

IVRO : 0.0600 (+19.05%)
IVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q2 2023 Results Newsfile - Thu May 11, 2023

Placentia, California--(Newsfile Corp. - May 11, 2023) - Today InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023 second...

IVRO : 0.0600 (+19.05%)
IVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q1 2023 Results Newsfile - Wed Feb 8, 2023

Placentia, California--(Newsfile Corp. - February 8, 2023) - Today InVitro International (OTC Pink: IVRO), the 37 year pioneer developer and marketer of animal free testing methods, announced first fiscal...

IVRO : 0.0600 (+19.05%)
IVRO'S Mission To Help Make Non-Animal Testing Famous Now Searches For Strategic Partners AccessWire - Wed Sep 1, 2021

PLACENTIA, CA / ACCESSWIRE / September 1, 2021 / InVitro International (OTC PINK:IVRO) announced today that it has taken a first step in its search for strategic partners. IVRO entered into Letter of Intent...

IVRO : 0.0600 (+19.05%)
IVRO Pursues Mission To "Help Make Non Animal Testing Famous"; Releases FY Q3 and YTD 2021 Results AccessWire - Wed Aug 4, 2021

PLACENTIA, CA / ACCESSWIRE / August 4, 2021 / InVitro International (OTC PINK:IVRO) is pleased to announce FY 2021 3rd quarter revenues of $310,700 and net income of $87,644. These sales were 35%+ vs same...

IVRO : 0.0600 (+19.05%)
IVRO Continues Its Mission To "Help Make Non Animal Testing Famous"; Releases FY Q2 and YTD 2021 Results AccessWire - Tue May 11, 2021

PLACENTIA, CA / ACCESSWIRE / May 11, 2021 / InVitro International (OTC PINK:IVRO) today announced net income of $10,094 for its first six months of fiscal 2021 and a net loss of $57,704 in the 2nd fiscal...

IVRO : 0.0600 (+19.05%)
Invitro International, A Pioneer in Non-Animal Testing Alternatives For Ocular and Dermal Toxicity Releases FY Q1 2021 Results AccessWire - Wed Feb 10, 2021

PLACENTIA, CA / ACCESSWIRE / February 10, 2021 / InVitro International (OTCPINK:IVRO) is pleased to announce net income of $67,663 in its first fiscal quarter of 2021, ending December 31st, 2020. This...

IVRO : 0.0600 (+19.05%)

Barchart Exclusives

3 High-Yield Dividend Stocks Ready to Soar Barchart - Fri May 3, 6:00PM CDT
These three stocks are cheap, pay a high dividend, and are highly rated. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot